Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 6:16:1546031.
doi: 10.3389/fimmu.2025.1546031. eCollection 2025.

Microbiota-friendly diet ameliorates hypoalbuminemia in chronic kidney disease: evidence from NHANES

Affiliations

Microbiota-friendly diet ameliorates hypoalbuminemia in chronic kidney disease: evidence from NHANES

Xiaoyan Wang et al. Front Immunol. .

Abstract

Chronic kidney disease (CKD) is a global health issue, affecting approximately 10% of the population. Hypoalbuminemia, a common complication in advanced CKD, is associated with poor prognosis. This study aimed to investigate the association between a microbiota-friendly dietary scoring system (Dietary Index for Gut Microbiota, DI-GM) and serum albumin levels in patients with CKD. We utilized a cross-sectional cohort from the NHANES 2007-2018, which included 2,947 CKD patients. Multivariable logistic regression and restricted cubic spline models were applied to analyze the relationship between DI-GM scores and serum albumin. Higher DI-GM scores were significantly associated with increased serum albumin levels (β = 0.18 g/L, 95% CI: 0.07-0.28, p = 0.002). Furthermore, each 1-point increase in DI-GM score was linked to a 15% reduction in the odds of hypoalbuminemia (OR: 0.85, 95% CI: 0.74-0.97, p = 0.014). The findings suggest that a high DI-GM diet may have beneficial effects in managing hypoalbuminemia in CKD patients by modulating gut microbiota composition and reducing inflammation. This diet pattern could be a promising dietary intervention for improving clinical outcomes in CKD patients, especially those at risk for malnutrition and inflammation.

Keywords: CKD; dietary index for gut microbiota; dietary pattern; hypoalbuminemia; serum albumin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Study Population and flowchart. #: Diagnosis of chronic kidney disease (CKD): estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m² or urinary albumin-to-creatinine ratio (UACR) ≥30 mg/g. Complete and reliable dietary intake data for calculating DI-GM. *Abnormal dietary records: <800 kcal/day or >4000 kcal/day for men; <500 kcal/day or >3500 kcal/day for women.
Figure 2
Figure 2
The Relationship Between Dietary Index for Gut Microbiota (DI-GM) and Refined Grains Intake with Serum Albumin Levels in CKD Patients Using Restricted Cubic Splines (RCS). DI-GM and Serum Albumin Levels: An RCS analysis revealed a nonlinear relationship (p = 0.004). Serum albumin levels significantly increase as the DI-GM score exceeds 5. Refined Grain Intake and Serum Albumin Levels: An RCS analysis showed a nonlinear relationship (p = 0.013). At approximately 5.28 oz. eq. of refined grains per day, albumin levels remain stable. However, intake beyond this point is associated with a decrease in serum albumin levels.
Figure 3
Figure 3
Subgroup Analysis of the relationship Between Dietary Index for Gut Microbiota (DI-GM), daily refined grain intake (oz.eq.) and Serum Albumin Levels in CKD Patients (A, B). The positive association between DI-GM and serum albumin levels was consistent across most subgroups, with stronger effects observed in males, smokers, individuals with lower BMI, and those with diabetes. The significant interaction by smoking status suggests that smoking may modify the relationship between DI-GM and serum albumin (A). Additionally, refined grain intake is consistently associated with lower serum albumin levels across most subgroups (B).

Similar articles

References

    1. Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. (2022) 12:7–11. doi: 10.1016/j.kisu.2021.11.003 - DOI - PMC - PubMed
    1. Kalantar-Zadeh K, Jafar TH, Nitsch D, Neuen BL, Perkovic V. Chronic kidney disease. Lancet. (2021) 398:786–802. doi: 10.1016/S0140-6736(21)00519-5 - DOI - PubMed
    1. Zhang X, Fang Y, Zou Z, Hong P, Zhuo Y, Xu Y, et al. . Risk factors for progression of CKD with and without diabetes. J Diabetes Res. (2022) 2022:1–12. doi: 10.1155/2022/9613062 - DOI - PMC - PubMed
    1. Levitt D, Levitt M. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. IJGM. (2016) 9:229–55. doi: 10.2147/IJGM.S102819 - DOI - PMC - PubMed
    1. Suzuki Y, Suda K, Matsuyama Y, Era S, Soejima A. Close relationship between redox state of human serum albumin and serum cysteine levels in non-diabetic CKD patients with various degrees of renal function. CN. (2014) 82:320–5. doi: 10.5414/CN108040 - DOI - PubMed

LinkOut - more resources